A Randomized Pilot Trial to test the feasibility of comparing anti-thymocyte globulin plus
post transplant cyclophosphamide with anti-thymocyte globulin alone to prevent chronic graft
versus host disease.
Phase:
Phase 2
Details
Lead Sponsor:
McMaster University
Collaborators:
Cell Therapy Transplant Canada Ozmosis Research Inc. Sanofi